Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
64,197,888
-
Share change
-
-601,615
-
Total reported value
-
$3,539,139,123
-
Put/Call ratio
-
104%
-
Price per share
-
$55.14
-
Number of holders
-
223
-
Value change
-
-$54,346,929
-
Number of buys
-
114
-
Number of sells
-
121
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q3 2020
As of 30 Sep 2020,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
223 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,197,888 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, BANK OF AMERICA CORP /DE/, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, and STATE STREET CORP.
This page lists
223
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.